Plasmodium falciparum infection induces T cell tolerance that is associated with decreased disease severity upon re-infection
Muñoz Sandoval D. et al, (2025), Journal of Experimental Medicine, 222
Diagnosis of Plasmodium falciparum malaria at very low parasitaemias using a commercially available LAMP assay and RDT.
Payne RO. et al, (2025), Transactions of the Royal Society of Tropical Medicine and Hygiene
Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children
Natama HM. et al, (2024), The Lancet Infectious Diseases
Synergistic blockade of TIGIT and PD-L1 increases type-1 inflammation and improves parasite control during murine blood-stage <i>Plasmodium yoelii</i> non-lethal infection.
Dookie RS. et al, (2024), Infection and immunity, 92
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial
Silk SE. et al, (2024), The Lancet Infectious Diseases, 24, 1105 - 1117
Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates.
Thiam LG. et al, (2024), NPJ vaccines, 9
Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5
Harrison TE. et al, (2024), EMBO Molecular Medicine, 16, 2539 - 2559
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.
Barrett JR. et al, (2024), Cell, 187, 4964 - 4980.e21
Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5
Wang LT. et al, (2024), Cell, 187, 4981 - 4995.e14
Plug and play virus-like particles for the generation of anti-toxin antibodies.
Edge RJ. et al, (2024), Toxicon: X, 23
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies.
King LDW. et al, (2024), Cell reports. Medicine, 5
Structure-guided design of aPlasmodium vivaxDuffy binding protein-based vaccine immunogen
Barber NM. et al, (2024)
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
Williams BG. et al, (2024), Nature Communications, 15
Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development
Mertens JE. et al, (2024), Vaccine, 42, 3621 - 3629
The PfRCR complex bridges malaria parasite and erythrocyte during invasion
Farrell B. et al, (2024), Nature, 625, 578 - 584